Literature DB >> 27527772

Molecular characterization of a feline calicivirus isolated from tiger and its pathogenesis in cats.

Jin Tian1, Dafei Liu2, Yongxiang Liu2, Hongxia Wu2, Yanmei Jiang3, Shaopo Zu4, Chunguo Liu2, Xue Sun4, Jiasen Liu2, Liandong Qu5.   

Abstract

Feline calicivirus (FCV) is a virus that causes respiratory disease in cats. In this study, the FCV TIG-1 was isolated from Siberian tiger feces collected in 2014 in Heilongjiang Province, China. Phylogenetic analysis among TIG-1 and other FCVs showed that TIG-1 does not share the same lineage with other FCV isolates from Heilongjiang or other regions in China but is located in the same cluster with the FCV strain Urbana, which was isolated from the United States. The growth kinetics in vitro and the pathogenicity in cats between TIG-1 and the domestic cat-origin FCV strain F9 (vaccine strain) and strain 2280 were compared. We found that the growth kinetics of strains TIG-1 and 2280 were faster than that of strain F9 from 12h to 36h post-infection, indicating that strains TIG-1 and 2280 produce infectious virions and reach peak yields earlier. Challenge experiments in cats showed that TIG-1 grew faster than the other two strains in the lungs of cats and that TIG-1 is a virulent FCV with 100% morbidity and lethality. In addition, the histopathological results showed that the virulent TIG-1 strain directly led to severe lung tissue damage and indirectly led to intestinal damage. The results presented here show that a tiger-origin FCV exhibits high virulence in cats.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Challenge experiments; Feline calicivirus; Phylogenetic analysis; Siberian tiger

Mesh:

Year:  2016        PMID: 27527772     DOI: 10.1016/j.vetmic.2016.07.005

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  7 in total

1.  Extracellular Vesicles (EVs) Are Copurified with Feline Calicivirus, yet EV-Enriched Fractions Remain Infectious.

Authors:  Rachel R Mizenko; Terza Brostoff; Kenneth Jackson; Patricia A Pesavento; Randy P Carney
Journal:  Microbiol Spectr       Date:  2022-07-25

2.  Icariin, Formononetin and Caffeic Acid Phenethyl Ester Inhibit Feline Calicivirus Replication In Vitro.

Authors:  Zhanding Cui; Qian Wang; Dengliang Li; Shihui Zhao; Qian Zhang; Yuxin Tan; Qianwen Gong; Ting Liu; Jiang Shao; Shuang Zhang; Hailong Huang; Junzheng Wang; Zhihua Pei; Hao Dong; Kai Wang; Guixue Hu; Zhiyong Li
Journal:  Arch Virol       Date:  2021-06-25       Impact factor: 2.574

3.  Feline Herpesvirus 1 US3 Blocks the Type I Interferon Signal Pathway by Targeting Interferon Regulatory Factor 3 Dimerization in a Kinase-Independent Manner.

Authors:  Jin Tian; Yongxiang Liu; Xiaoxiao Liu; Xue Sun; Jikai Zhang; Liandong Qu
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

4.  Feline Calicivirus Proteinase-Polymerase Protein Degrades mRNAs To Inhibit Host Gene Expression.

Authors:  Hongxia Wu; Jiapei Huang; Yongxiang Liu; Yudi Pan; Yin Li; Qian Miao; Liandong Qu; Jin Tian
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

5.  Feline calicivirus strain 2280 p30 antagonizes type I interferon-mediated antiviral innate immunity through directly degrading IFNAR1 mRNA.

Authors:  Jin Tian; Hongtao Kang; Jiapei Huang; Zhijie Li; Yudi Pan; Yin Li; Si Chen; Jikai Zhang; Hang Yin; Liandong Qu
Journal:  PLoS Pathog       Date:  2020-10-19       Impact factor: 6.823

6.  N-Terminal Domain of Feline Calicivirus (FCV) Proteinase-Polymerase Contributes to the Inhibition of Host Cell Transcription.

Authors:  Hongxia Wu; Shaopo Zu; Xue Sun; Yongxiang Liu; Jin Tian; Liandong Qu
Journal:  Viruses       Date:  2016-07-20       Impact factor: 5.048

7.  Identification of Feline Interferon Regulatory Factor 1 as an Efficient Antiviral Factor against the Replication of Feline Calicivirus and Other Feline Viruses.

Authors:  Yongxiang Liu; Xiaoxiao Liu; Hongtao Kang; Xiaoliang Hu; Jiasen Liu; Jin Tian; Liandong Qu
Journal:  Biomed Res Int       Date:  2018-06-12       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.